14 January 2020

Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by researchers from Radboud university medical center. Following abdominal surgery, 4.7% of all patients are still re-admitted for complications due to adhesions. Measures to achieve further reductions in the disease burden—including for abdominal surgery—are urgently needed.

Internal scar tissue emerges relatively frequently following abdominal surgery. Such ‘adhesions’ can have far-reaching consequences. In a 2013 article in British Medical Journal, the surgical resident Richard ten Broek presented an overview of the most important complications (e.g., acute ileus, chronic pain, intestinal injuries from repeat surgeries, and decreased fertility). Adhesions thus constitute a serious medical problem.

The first large-scale study on adhesions (the SCAR study) was conducted in 1999, in which all patients in Scotland who had undergone abdominal surgery were followed. Of these patients, 5% were re-admitted in subsequent years due to complications that were definitely caused by adhesions. In addition, one third of all patients were re-admitted for complaints that were possibly consistent with complications from adhesions.
 
Fewer adhesions due to keyhole surgery
“The SCAR study was a catalyst for anti-adhesion drugs,” notes ten Broek from Radboudumc, “but most of these drugs were suitable for open surgery, which involves actually opening up the abdomen. At the time that these drugs were introduced, surgeons were increasingly shifting to laparoscopy—to minimally invasive keyhole operations.”

Although it was assumed that keyhole operations would result in fewer adhesions, it would be a long time before we could know the exact reduction in the number of adhesions or whether such techniques also led to other complications. Ten Broek: “In a recent publication, the ten Broek/van Goor research group demonstrates that, following open surgery, adhesions occur in nearly 90% of all patients. After laparoscopy, the number is about 70%. In addition, the adhesions occurring with open surgery are often more extensive, particularly in the direction of the abdominal wall.”
 
Fewer, but still too many
To improve the comparability of figures, ten Broek and his colleagues re-used the data from the Scottish databank to investigate re-admissions. This SCAR update, which was published in The Lancet, indicates that keyhole surgery reduces the risk of re-admissions due to adhesions. This reduction was 30% for re-admissions that were definitely due to adhesions, and 10% for complications that might have been associated with adhesions.

This seems to be good news. “Absolutely”, states ten Broek, “any decrease in the number of adhesions is more than welcome. Nevertheless, the total disease burden is still high. Too high. Of all patients who have had surgery, 4.7% are still re-admitted for complications due to adhesions, and about 30% are re-admitted for complications that might be associated with adhesions. In 1999, the total disease burden was virtually the same (re-admission rates of 5% and more than 30%, respectively). The risk of complications within certain groups (e.g., surgery on the large intestine or gynecological procedures) also remains high, even for keyhole operations. Although keyhole surgery has reduced the risk of adhesions, the disease burden for adhesions is still too high, even for laparoscopy. We must continue working to reduce these risks even further, while increasing the use of anti-adhesion drugs.”

Publicatie in The Lancet 
Adhesion-related readmissions after open and laparoscopic surgery: a retrospective cohort study (SCAR update) - Pepijn Krielen, Martijn W J Stommel, Pille Pargmae, Nicole D Bouvy, Erica A Bakkum, Harold Ellis, Michael C Parker, Ewen A Griffiths, Harry van Goor, Richard P G ten Broek
 

Related news items


Prinses Beatrix Spierfonds grant to investigate patient stratification in myotonic dystrophy

24 January 2020

Rick Wansink and Roland Brock, both theme Nanomedicine, received a € 280,000 grant from the Prinses Beatrix Spierfonds.

read more

RIMLS PhD retreat registration is open

23 January 2020

Yearly, RIMLS PhD candidates gather for the two-day PhD Retreat. Apart from the science, this event is highly valued for the opportunity to meet and get to know fellow PhD candidates during the social activities. Early bird registration and abstract submission deadline: 4 March 2020.

read more

Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment

23 January 2020

In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.

read more

6 million euros to uncover link between metabolic and brain disorders

21 January 2020

An important European-funded initiative, coordinated by Radboudumc researchers Barbara Franke, Jan Buitelaar, and Janita Bralten, has been launched to explore how common molecular mechanisms may link metabolic disorders with brain disorders.

read more

NWO Open Competition Domain Science - XS grant for Ronald van Rij and Jenny van der Wijst

21 January 2020

NWO Domain Science has awarded Ronald van Rij, theme Infectious diseases and global health and Jennny van der Wijst, theme Renal disorders an XS grant. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea.

read more

First BeNeFit funding granted for psoriasis

17 January 2020

RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

read more